ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977

First “Annual” CCOP RFA Issued; Research Bases Must Compete

June 8, 1990

FDA Offers Grants For Conferences

May 1, 1987

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989